• Profile
Close

Combining pretreatment plasma Epstein-Barr virus DNA level and cervical node necrosis improves prognostic stratification in patients with nasopharyngeal carcinoma: A cohort study

Cancer Medicine Oct 12, 2019

Du YY, Luo DH, Sun XS, et al. - In this review of 607 incident nonmetastatic nasopharyngeal carcinoma (NPC) patients who had received intensity-modulated radiotherapy (IMRT) ± chemotherapy, researchers investigated whether combining pretreatment Epstein-Barr virus (EBV) DNA level and cervical node necrosis (CNN) has any prognostic value for patients receiving IMRT. They found pretreatment EBV DNA level and CNN status behaved as independent prognostic factors. Significantly better 5-year progression-free survival (PFS) was observed in patients in the low-level EBV DNA group or non-CNN group. For overall survival, PFS, distant metastasis-free survival, but not for locoregional relapse-free survival, an independent prognostic role of CNN was revealed in multivariate analyses. Findings revealed a close correlation of both pretreatment plasma EBV DNA level and CNN status with the prognosis of NPC patients in the IMRT era. Better risk stratification and prognostic value can be achieved by combining EBV DNA level and CNN status.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay